Nuva Ring Lawsuit
Nuva Ring Lawsuit Information
NuvaRing is a birth control device developed by Organon a multi-billion dollar European pharmaceutical company.
Nuva Ring works by releasing estrogen and progesterone into the bloodstream. It releases estrogen and progesterone into the bloodstream. However, these high levels of hormones are known cause blood clotting issues, such as blood clots and could cause severe health consequences.
The increased health risks related to Nuva Ring include but are not limited to;
* Strokes
* Heart Attacks
* Bloodclots
* Cerebral Hemorrhaging
* Cardiovascular Accidents
* Myocardial Infarction
* Pulmonary Embolisim
These side effects were known and documented for several years, yet the public was never warned and Nuva Ring was sold and marketed to U.S. consumers.
Birth control products utilizing the manipulation of hormone levels have been on the market for many years, and have undergone their share of controversy in the medical community. Many have proven to be relatively safe; some have remained controversial and at least one is now being sited in multiple lawsuits as the cause of serious medical problems and at least one fatality.
NuvaRing is an internal birth control device, a vaginal ring placed near the cervix that was approved by the FDA in 2001. The manufacturer is the Organon Pharmaceuticals, working in conjunction with Schering Plough to market the product. NuvaRing releases two synthetically produced hormones, progestin and an estrogen, into the woman’s body. The combination of these hormones is designed to both prevent ovulation and minimize sperm penetration – a double phalanx against unwanted pregnancy.
Use of the device over the past seven years has shown that side effects of NuvaRing can include vaginitis, headache, nausea, and possible upper respiratory tract infections that include sinusitis. More serious problems have also developed in the form of blood clots that can cause deep vein thrombosis and life threatening pulmonary embolism.
NuvaRing has been described as a third-generation birth control product using a form of synthetic progestin called desogestrel. Use of this particular synthesized version of the hormone has been associated with a higher risk of blood clots in women when compared with the use of earlier contraceptives that used the same scientific concept with different formulations of progestin.
Fifty or more NuvaRing lawsuits have been filed as the result of blood clotting problems resulting in deep vein thrombosis or pulmonary embolism, which is clotting in the primary artery feeding oxygen to the lungs. There is discussion of a class action lawsuit against Organon and affiliated companies over this birth control device and some women have already taken the step of filing legal action on their own.
In 2005, the FDA issued a warning about NuvaRing that detailed reports of abnormal bleeding and spotting from use of the device, as well as advising that “the increased risk of thromboembolic and thrombotic disease associated with use of the vaginal ring, it should not be used in women with valvular heart disease and thrombogenic complications.”
The operative notation in this warning with respect to blood clotting is the increased risk of thromboemolism, which is a condition wherein a blood clot breaks loose from its formation location and is carried through the bloodstream to another point where it creates blockage. The NuvaRing lawsuits are based on occurrences that have been observed by medical authorities and commented on by the FDA at least three years ago.
If you or a family member is exhibiting any of the symptoms associated with the use of the NuvaRing including blood clotting health problems, contact our law firm for a free review of your case and some suggestions about how to act on it.
This post is written by
Trackbacks/Pingbacks
[...] According to court documents, on February 3rd, 2012, a Pennsylvania woman, Aimee L. Flynn filed a lawsuit (case no. 2:2012cv00700) in the U.S. District Court for the District of New Jersey claiming that she suffered a stroke on February 5, 2010 caused by NuvaRing. The lawsuit names Merck & Co., Organon Pharmaceuticals, Akzo Nobel NV and Schering-Plough Corporation as defendants. NuvaRing is a popular internal birth control device, a vaginal ring placed near the cervix that was approved by the FDA in 2001. In 2011, the FDA published a birth control study revealing that the NuvaRing raised the risk of blood clots by 56% when compared to older birth control pills. This new NuvaRing lawsuit, together with a growing number of NuvaRing lawsuits, is likely to be transferred to the U.S. District Court for the Eastern District of Missouri to be included in the MDLA which is centralized. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of NuvaRing severe adverse events. http://www.attorneyone.com/nuva-ring-lawsuit/ [...]
[...] According to court documents, on February 3rd, 2012, a Pennsylvania woman, Aimee L. Flynn filed a lawsuit (case no. 2:2012cv00700) in the U.S. District Court for the District of New Jersey claiming that she suffered a stroke on February 5, 2010 caused by NuvaRing. The lawsuit names Merck & Co., Organon Pharmaceuticals, Akzo Nobel NV and Schering-Plough Corporation as defendants. NuvaRing is a popular internal birth control device, a vaginal ring placed near the cervix that was approved by the FDA in 2001. In 2011, the FDA published a birth control study revealing that the NuvaRing raised the risk of blood clots by 56% when compared to older birth control pills. This new NuvaRing lawsuit, together with a growing number of NuvaRing lawsuits, is likely to be transferred to the U.S. District Court for the Eastern District of Missouri to be included in the MDLA which is centralized. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of NuvaRing severe adverse events. http://www.attorneyone.com/nuva-ring-lawsuit/ [...]
[...] counsel so anyone can easily and inexpensively deal with cases of NuvaRing severe adverse events [http://www.attorneyone.com/nuva-ring-lawsuit/ [...]
[...] New Lawsuit on NuvaRing Alleging Acute Pulmonary Embolism June 12, 2012 According to court documents, on May 30th, 2012, an Iowa woman, Kristina Marie Isaac, filed a lawsuit in New Jersey District Court (case no. 2:2012cv03240) alleging that her NuvaRing caused her an acute pulmonary embolism. NuvaRing is a popular internal birth control device, a vaginal ring placed near the cervix that was approved by the FDA in 2001. A study published on May 10th 2012 in the British Medical Journal revealed that women who used a vaginal ring had a 6.5 times higher risk for developing blood clots compared to non-users of hormonal contraception. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of NuvaRing severe adverse events. [http://www.attorneyone.com/nuva-ring-lawsuit/ [...]
[...] According to court documents, on May 30th, 2012, an Iowa woman, Kristina Marie Isaac, filed a lawsuit in New Jersey District Court (case no. 2:2012cv03240) alleging that her NuvaRing caused her an acute pulmonary embolism. NuvaRing is a popular internal birth control device, a vaginal ring placed near the cervix that was approved by the FDA in 2001. A study published on May 10th 2012 in the British Medical Journal revealed that women who used a vaginal ring had a 6.5 times higher risk for developing blood clots compared to non-users of hormonal contraception. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of NuvaRing severe adverse events. [http://www.attorneyone.com/nuva-ring-lawsuit/ [...]
[...] is often a double-edged sword. No one knows this better than Trina M. Gatling and women who filed a NuvaRing Recall lawsuit. And yet, the real story here is being overlooked according to Sean Burke of [...]
[...] New Lawsuit on NuvaRing Deep Vein Thrombosis August 16, 2012 According to court documents, on June 28th, 2012, North Carolina resident Trina M. Gatling filed a lawsuit in New Jersey District Court (case no. 2:2012cv03990) alleging that she suffered deep vein thrombosis caused by her NuvaRing. NuvaRing is a contraceptive that comes in the form of a vaginal ring using female hormones in an effort to prevent ovulation. NuvaRing was approved by the FDA in October 2001 and it is marketed and sold by the Organon USA Inc. As of Dec. 31st 2011, approximately 950 lawsuits were pending, alleging injuries sustained from NuvaRing use, including some alleged deaths, heart attacks and strokes. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of NuvaRing severe adverse events [http://www.attorneyone.com/nuva-ring-lawsuit/ [...]